<qa>  How many subjects will be enrolled in two sequential dose cohorts?The study will consist of a Screening period up to 14 days, a Treatment period, and a Follow-Up period. Sixteen subjects will be enrolled into two sequential dose cohorts - 10 or 30 mg or matching placebo across four study centers. 